BioCentury | Oct 13, 2017
Financial News

ObsEva prices $60M private placement

...$8. Investors included existing shareholders New Enterprise Associates , New Leaf Venture Partners, Sofinnova Ventures, DAFNA Capital Management...
BioCentury | Oct 10, 2017
Financial News

ObsEva prices $60M private placement

...$8. Investors included existing shareholders New Enterprise Associates , New Leaf Venture Partners, Sofinnova Ventures, DAFNA Capital Management...
BioCentury | Jul 18, 2016
Financial News

Ardelyx proposes private placement

...RA Capital Management; First Manhattan; Rock Springs Capital; Cormorant Asset Management; Perceptive Advisors; Deerfield Management; DAFNA Capital Management...
BioCentury | Jun 6, 2016
Financial News

argenx completes private placement

...EUR11.10 Shares after offering: 20 million Investors: MPM Oncology Impact Fund; Aquilo Capital; Burrage Capital; DAFNA Capital Management...
BioCentury | Apr 6, 2015
Financial News

Cynapsus completes private placement

...Science Partners Investors: OrbiMed Advisors; Aisling Capital ; Venrock; Broadfin Capital; Sphera Global Healthcare Fund; DAFNA Capital Management...
BioCentury | Jan 19, 2015
Financial News

Aldeyra Therapeutics completes private placement of common stock and warrants

...offering: 6.7 million Placement agent: Laidlaw Investors: Perceptive Advisors; Knoll Capital; Sphera Global Healthcare Fund; DAFNA Capital Management...
BioCentury | Mar 30, 2009
Finance

2Q Financial Markets Preview: Post-Genentech world

...a fraction is likely to go to the small caps. Fariba Ghodsian, portfolio manager at Dafna Capital Management...
BioCentury | Jan 5, 2009
Finance

2009 Financial Markets Preview: Weathering (nuclear)winter

...The antibody company sold 9.4 million units at $4.25 to a syndicate including Index; Abingworth; DAFNA Capital Management...
BioCentury | Oct 4, 2008
Financial News

Micromet raises $40 million

...private placement of 9.4 million units at $4.25 per unit. Investors included Index Ventures; Abingworth; DAFNA Capital Management...
BioCentury | Jan 8, 2007
Finance

Value vs. opportunity

...B-type natriuretic peptide that is marketed for acute heart failure by JNJ. Fariba Ghodsian of Dafna Capital Management...
Items per page:
1 - 10 of 13
BioCentury | Oct 13, 2017
Financial News

ObsEva prices $60M private placement

...$8. Investors included existing shareholders New Enterprise Associates , New Leaf Venture Partners, Sofinnova Ventures, DAFNA Capital Management...
BioCentury | Oct 10, 2017
Financial News

ObsEva prices $60M private placement

...$8. Investors included existing shareholders New Enterprise Associates , New Leaf Venture Partners, Sofinnova Ventures, DAFNA Capital Management...
BioCentury | Jul 18, 2016
Financial News

Ardelyx proposes private placement

...RA Capital Management; First Manhattan; Rock Springs Capital; Cormorant Asset Management; Perceptive Advisors; Deerfield Management; DAFNA Capital Management...
BioCentury | Jun 6, 2016
Financial News

argenx completes private placement

...EUR11.10 Shares after offering: 20 million Investors: MPM Oncology Impact Fund; Aquilo Capital; Burrage Capital; DAFNA Capital Management...
BioCentury | Apr 6, 2015
Financial News

Cynapsus completes private placement

...Science Partners Investors: OrbiMed Advisors; Aisling Capital ; Venrock; Broadfin Capital; Sphera Global Healthcare Fund; DAFNA Capital Management...
BioCentury | Jan 19, 2015
Financial News

Aldeyra Therapeutics completes private placement of common stock and warrants

...offering: 6.7 million Placement agent: Laidlaw Investors: Perceptive Advisors; Knoll Capital; Sphera Global Healthcare Fund; DAFNA Capital Management...
BioCentury | Mar 30, 2009
Finance

2Q Financial Markets Preview: Post-Genentech world

...a fraction is likely to go to the small caps. Fariba Ghodsian, portfolio manager at Dafna Capital Management...
BioCentury | Jan 5, 2009
Finance

2009 Financial Markets Preview: Weathering (nuclear)winter

...The antibody company sold 9.4 million units at $4.25 to a syndicate including Index; Abingworth; DAFNA Capital Management...
BioCentury | Oct 4, 2008
Financial News

Micromet raises $40 million

...private placement of 9.4 million units at $4.25 per unit. Investors included Index Ventures; Abingworth; DAFNA Capital Management...
BioCentury | Jan 8, 2007
Finance

Value vs. opportunity

...B-type natriuretic peptide that is marketed for acute heart failure by JNJ. Fariba Ghodsian of Dafna Capital Management...
Items per page:
1 - 10 of 13